Yakult Honsha And OncoTherapy Science, Inc. To Team Up In R&D For New Antibody Drugs For Lung Cancer Treatments
10/19/2005 5:11:05 PM
Yakult Honsha has announced that it has agreed with OncoTherapy Science to collaborate in R&D in the field of antibody drugs for cancer treatments.
Under this alliance, the two companies will strive to develop new antibody drugs aimed at the treatment of lung cancer.
|